Natco Pharma Ltd. (NATCOPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 156274, "name": "Natco Pharma", "stock_name": "Natco Pharma", "full_name": "Natco Pharma Ltd.", "name_url": "stocks-analysis/natco-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "917.15", "chg": 4.8, "chgp": "0.53%", "dir": 1, "prev_price": "912.35", "mcapval": "16,360.00 Cr", "mcap": "Small Cap", "scripcode": 524816, "symbol": "NATCOPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE987B01026", "curr_date": "Aug 07, 03:30 PM", "curr_time": "18:54 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "1.75 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Natco Pharma Declines 0.29%: Mixed Technical Signals and Downgrade Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-declines-029-mixed-technical-signals-and-downgrade-shape-weekly-trend-4144272", "imagepath": "", "date": "2026-08-09 15:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>4 Aug:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>4 Aug:</strong> Mild bullish technical momentum observed despite bearish signals</p>\n <p><strong>5 Aug:</strong> Downgrade to Sell following weak financials and bearish technicals</p>\n <p><strong>5 Aug:</strong> Technical momentum shifts to mildly bearish stance</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.919..." }, { "title": "When is the next results date for Natco Pharma Ltd.?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-natco-pharma-ltd-4142300", "imagepath": "", "date": "2026-08-07 23:19:06", "description": "The next results date for Natco Pharma Ltd. is scheduled for 14 August 2026...." }, { "title": "Natco Pharma Downgraded to Sell Amid Weak Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-downgraded-to-sell-amid-weak-financials-and-bearish-technicals-4137275", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NatcoPharmaLtd_mojoScore_4137275.png", "date": "2026-08-05 08:17:46", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 August 2026. This shift reflects deteriorating financial performance, subdued valuation appeal, and a weakening technical outlook, signalling caution for investors amid challenging market conditions." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-bearish-signals-4136669", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NatcoPharmaLtd_technicaldot_4136669.png", "date": "2026-08-05 08:00:35", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This change is reflected in key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, signalling a cautious outlook for investors amid recent price declines and mixed trend signals." }, { "title": "Natco Pharma Ltd. Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-forms-death-cross-signalling-potential-bearish-trend-4136086", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NatcoPharmaLtd_dealthcross_4136086.png", "date": "2026-08-04 18:00:20", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about long-term weakness amid mixed fundamental and technical metrics." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4134361", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NatcoPharmaLtd_technicaldot_4134361.png", "date": "2026-08-04 08:01:06", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting cautious optimism among traders and investors as the stock navigates current market conditions." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4132788", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NatcoPharmaLtd_technicaldot_4132788.png", "date": "2026-08-03 08:00:26", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 27 July 2026, the stock’s technical indicators present a complex picture, reflecting mixed signals across multiple timeframes and metrics." }, { "title": "Natco Pharma’s Mixed Week: -0.10% Price Change Amid Technical Shift and Financial Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharmas-mixed-week--010-price-change-amid-technical-shift-and-financial-challenges-4132533", "imagepath": "", "date": "2026-08-02 15:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens at Rs.927.15 with technical upgrade to Hold</p>\n <p><strong>28 Jul:</strong> Technical momentum shifts signal mild bullish outlook</p>\n <p><strong>29 Jul:</strong> Stock rebounds with 1.18% gain amid positive technical sentiment</p>\n <p><strong>30 Jul:</strong> Slight pullback despite Sensex gains</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.919.85, down 0.10% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.920.80</div></div>\n ..." }, { "title": "Natco Pharma Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4123602", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NatcoPharmaLtd_mojoScore_4123602.png", "date": "2026-07-28 08:27:25", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 27 July 2026. This change reflects a nuanced reassessment of the company’s quality, valuation, financial trends, and technical indicators amid a challenging operating environment and mixed performance metrics." } ], "total": 5670, "sid": "156274", "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274" }, "announcements": [ { "caption": "Board Meeting Intimation for Considering Un-Audited Financial Results For The Quarter Ended 30Th June 2026 And Declare Interim Dividend If Any", "datetime": "06-Aug-2026", "details": "Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30th June 2026 and declare Interim Dividend if any for the FY 2026-27", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "18-Jul-2026", "details": "Press Release: NATCO receives Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order", "datetime": "14-Jul-2026", "details": "Order passed by Assistant Commissioner (ST)(FAC) Tenali Circle Tenali Andhra Pradesh", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "14 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26", "dt": "2026-02-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15", "dt": "2015-11-26", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Technical momentum shifts amid mixed market signals

4 Aug: Death Cross formation signals potential bearish trend

4 Aug: Mild bullish technical momentum observed despite bearish signals

5 Aug: Downgrade to Sell following weak financials and bearish technicals

5 Aug: Technical momentum shifts to mildly bearish stance

Week Open

Rs.919...

Read full news article

When is the next results date for Natco Pharma Ltd.?

2026-08-07 23:19:06

The next results date for Natco Pharma Ltd. is scheduled for 14 August 2026....

Read full news article

Natco Pharma Downgraded to Sell Amid Weak Financials and Bearish Technicals

2026-08-05 08:17:46

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 August 2026. This shift reflects deteriorating financial performance, subdued valuation appeal, and a weakening technical outlook, signalling caution for investors amid challenging market conditions.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Bearish Signals

2026-08-05 08:00:35

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This change is reflected in key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, signalling a cautious outlook for investors amid recent price declines and mixed trend signals.

Read full news article

Natco Pharma Ltd. Forms Death Cross, Signalling Potential Bearish Trend

2026-08-04 18:00:20

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about long-term weakness amid mixed fundamental and technical metrics.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Signal Mild Bullish Outlook

2026-08-04 08:01:06

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting cautious optimism among traders and investors as the stock navigates current market conditions.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-08-03 08:00:26

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 27 July 2026, the stock’s technical indicators present a complex picture, reflecting mixed signals across multiple timeframes and metrics.

Read full news article

Natco Pharma’s Mixed Week: -0.10% Price Change Amid Technical Shift and Financial Challenges

2026-08-02 15:00:05

Key Events This Week

27 Jul: Stock opens at Rs.927.15 with technical upgrade to Hold

28 Jul: Technical momentum shifts signal mild bullish outlook

29 Jul: Stock rebounds with 1.18% gain amid positive technical sentiment

30 Jul: Slight pullback despite Sensex gains

31 Jul: Week closes at Rs.919.85, down 0.10% for the week

Week Open

Rs.920.80

...

Read full news article

Natco Pharma Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-07-28 08:27:25

Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 27 July 2026. This change reflects a nuanced reassessment of the company’s quality, valuation, financial trends, and technical indicators amid a challenging operating environment and mixed performance metrics.

Read full news article

View All News